ZVSA

0.00010.00%
PW

Peter Wolfe

CFO & Secretary

Mr. Peter Wolfe serves as CFO and Director of Digital Health Dialog LLC. He serves as Chief Financial Officer and Secretary at ZyVersa Therapeutics, Inc. since December 12, 2022. Mr. Wolfe had been Senior Vice President of Finance and Administration of ZyVersa Therapeutics, Inc. (formerly, Variant Pharmaceuticals, Inc.) from 2019 to December 2022, and prior to that had served as Vice President of Finance from October 2015 to 2019. He served as Acting Vice President of Finance at Variant Pharmaceuticals, Inc. Mr. Wolfe has spent his career in various financial roles in the financial services, specialty finance and the pharmaceutical/healthcare industries. Mr. Wolfe has spent his time cultivating start-up organizations in various healthcare entities, often dealing with complicated business models to develop a financial framework for success for many of these first of their kind businesses. Mr. Wolfe has spent the last 17 years of his career in the healthcare industry with half of that time spent at Kos Pharmaceuticals, a publicly traded, fully-integrated specialty pharmaceutical company. Mr. Wolfe assisted in guiding Kos to 27 straight quarters of meeting or exceeding Wall Street quarterly earnings estimates. Mr. Wolfe has his BBA from the University of Miami and his MBA from the University of Pittsburgh.

Positions